Prescription stimulants are used primarily to treat ADHD, narcolepsy, binge eating disorder, obesity, and obstructive sleep apnea. They work by boosting the activity of certain chemical messengers in the brain, which improves focus, wakefulness, and impulse control depending on the condition being treated.
How Stimulants Work in the Brain
Stimulants increase the availability of two key chemical messengers, dopamine and norepinephrine, in the front part of the brain responsible for planning, attention, and decision-making. Dopamine helps filter out distracting “noise,” while norepinephrine strengthens the signals your brain is trying to focus on. The combined effect makes it easier to process information, stay on task, and regulate impulses.
This mechanism is why stimulants can treat conditions that seem quite different from one another. A person with ADHD and a person with narcolepsy have different problems, but both benefit from a brain that’s better at sustaining attention and staying alert.
ADHD
ADHD is by far the most common reason stimulants are prescribed. Between 70% and 80% of children with ADHD experience fewer symptoms when taking stimulant medication, making these drugs the most effective single treatment for the condition. The core symptoms they target are inattention, hyperactivity, and impulsivity.
For many people, the practical result is being able to sit through a meeting, finish homework, or follow a conversation without constantly losing the thread. Stimulants don’t cure ADHD; they manage it for the hours the medication is active. That’s why the choice between short-acting and long-acting formulations matters. Short-acting versions provide relief for roughly 4 to 6 hours, so you may need a morning and afternoon dose. Extended-release versions last 8 to 12 hours on a single morning dose, covering a full school or work day without the midday interruption.
Adults and children both use stimulants for ADHD, and the medications are often combined with behavioral strategies, organizational tools, or therapy for the best overall results.
Narcolepsy and Excessive Sleepiness
Narcolepsy causes overwhelming daytime sleepiness and, in some cases, sudden episodes of muscle weakness triggered by emotions (called cataplexy). Stimulants that act on the central nervous system are the primary treatment for staying awake during the day.
Newer options tend to be first-line choices because they carry a lower risk of dependence and don’t produce the sharp energy spikes and crashes associated with older stimulants. When those aren’t enough, stronger stimulants like methylphenidate or amphetamine-based medications are used instead. These are effective but require closer monitoring because they can be habit-forming.
Stimulants are also sometimes prescribed as an add-on treatment for obstructive sleep apnea, specifically for people who remain excessively sleepy during the day even after using a CPAP machine or other primary treatments.
Binge Eating Disorder
Binge eating disorder (BED) involves recurring episodes of eating large amounts of food with a feeling of loss of control. One specific stimulant, lisdexamfetamine, is FDA-approved for moderate to severe BED in adults. It’s the only stimulant with this approval.
The evidence behind it is striking. In a randomized trial of 418 adults, those who stayed on lisdexamfetamine had a relapse rate of just 3.7% over six months, compared to 32.1% for those switched to a placebo. That translates to roughly 11 times lower risk of relapsing into binge eating episodes. The medication appears to reduce the compulsive drive to binge rather than simply suppressing appetite, though appetite reduction can also occur.
Obesity
Certain stimulants are FDA-approved for short-term treatment of exogenous obesity, defined as a BMI of 30 or higher. These work partly by suppressing appetite and partly by increasing the body’s energy expenditure. However, stimulant-based weight loss medications are generally considered a less favored option today compared to newer drug classes, and they’re typically reserved for short-term use rather than ongoing management.
Off-Label Uses
Doctors sometimes prescribe stimulants for conditions outside their official approvals. The two best-supported off-label uses are treatment-resistant depression and recovery from traumatic brain injury. In older adults with depression that hasn’t responded to standard antidepressants, stimulants can sometimes provide a meaningful boost in energy and motivation. After a traumatic brain injury, they may help with cognitive sluggishness and difficulty concentrating during rehabilitation.
Less common off-label uses include managing fatigue from neurological conditions like multiple sclerosis, addressing symptoms of PTSD, and treating excessive daytime sleepiness that doesn’t qualify as narcolepsy. These uses have weaker evidence behind them and are typically considered only after first-line treatments have failed.
How They’re Classified and Monitored
Most prescription stimulants, including amphetamine and methylphenidate, are classified as Schedule II controlled substances by the DEA. This is the same category as opioid painkillers, reflecting their recognized medical value alongside a high potential for abuse and dependence. In practical terms, this means prescriptions usually can’t be called in by phone, often can’t be refilled without a new prescription, and may require more frequent office visits than non-controlled medications.
Because stimulants can raise heart rate and blood pressure, your doctor will typically check both before starting treatment and at regular intervals afterward. Routine heart monitoring with an ECG is not required for most patients, even after dose changes. Weight is also tracked, especially in children, since stimulants can suppress appetite enough to affect growth over time. If blood pressure stays persistently elevated despite dose adjustments, stimulant therapy may need to be stopped.
Short-Acting vs. Long-Acting Formulations
Most stimulant medications come in two versions. Immediate-release (IR) formulations kick in quickly and wear off in about 4 to 6 hours. You typically take them once or twice a day. Extended-release (XR or ER) versions release medication gradually over 8 to 12 hours, requiring just one morning dose.
The choice between them depends on your daily needs. Someone who only needs focus for a few hours of study might prefer a short-acting version, while someone working a full day usually benefits from extended release. Some people use both: a long-acting dose in the morning with a short-acting “booster” in the late afternoon if symptoms return before the evening. The active ingredients are identical in both versions. The difference is purely in how the pill delivers them over time.